TRUHvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with TRUH, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
TRUH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TRUH ETF 2 | +4.65%– | +10.09%– | n/a– | n/a– | n/a– | n/a– |
| Flows | TRUH ETF 2 | -– | -$289K– | -– | -– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TRUH ETF 2 | +17.56%– | n/a– | n/a– | n/a– |
| Max drawdown | TRUH ETF 2 | -5.82%– | n/a– | n/a– | n/a– |
| Max drawdown duration | TRUH ETF 2 | 56d– | n/a– | n/a– | n/a– |
Trading data
TRUH | ETF 2 | |
Last sale 10/28/2026 at 1:30 PM | $31.34 | – |
| Previous close 10/27/2026 | $31.27 | – |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
TRUH | ETF 2 | |
|---|---|---|
| Last price | $31.34 | – |
| 1D performance | +0.22% | – |
| AuM | $0.62 M | – |
| E/R | 0.1% | – |
Characteristics
TRUH | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | VanEck | – |
| Benchmark | - | – |
| N° of holdings | 59 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 1, 2026 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
TRUH
USA
97.67%
Other
2.33%
ETF 2
Sectors
TRUH
Healthcare
97.97%
Other
2.03%
ETF 2
Advertisement
Diversification
TRUH
Total weight of top 15 holdings out of 15
71.6%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
TRUH
Eli Lilly & Co.
14.98%
Johnson & Johnson
10.42%
AbbVie, Inc.
7.37%
Merck & Co., Inc.
5.94%
UnitedHealth Group, Inc.
5.76%
Amgen, Inc.
3.76%
Thermo Fisher Scientific, Inc.
3.74%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.98%
Pfizer Inc.
2.65%
Vertex Pharmaceuticals, Inc.
2.29%
Bristol Myers Squibb Co.
2.22%
Intuitive Surgical, Inc.
2.22%
Danaher Corp.
2.19%
CVS Health Corp.
1.96%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
